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ABSTRACT: Asparagine (N)-linked glycosylation is essential
for eﬃcient protein folding in the endoplasmic reticulum (ER)
and anterograde traﬃcking through the secretory pathway. N-
Glycans are attached to nascent polypeptides at consensus
sites, N-X-T/S (X ≠ P), by one of two enzymatic isoforms of
the oligosaccharyltransferase (OST), STT3A or STT3B. Here,
we examined the eﬀect of the consensus site X and hydroxyl
residue on the distributions of co- and post-translational N-
glycosylation of a type I transmembrane glycopeptide scaﬀold.
Using rapid radioactive pulse−chase experiments to resolve co-
translational (STT3A) and post-translational (STT3B) events, we determined that NXS consensus sites containing large
hydrophobic and negatively charged middle residues are frequently skipped by STT3A during protein translation. Post-
translational modiﬁcation of the cotranslationally skipped sites by STT3B was similarly hindered by the middle X residue,
resulting in hypoglycosylation of NXS sites containing large hydrophobic and negatively charged side chains. In contrast, NXT
consensus sites (barring NWT) were eﬃciently modiﬁed by the cotranslational machinery, reducing STT3B’s role in modifying
consensus sites skipped during protein translation. A strong correlation between cotranslational N-glycosylation eﬃciency and
the rate of post-translational N-glycosylation was determined, showing that the OST STT3A and STT3B isoforms are similarly
inﬂuenced by the hydroxyl and middle X consensus site residues. Substituting various middle X residues into an OST eubacterial
homologous structure revealed that small and polar consensus site X residues ﬁt well in the peptide binding site whereas large
hydrophobic and negatively charged residues were harder to accommodate, indicating conserved enzymatic mechanisms for the
mammalian OST isoforms.
The vast majority of secretory and integral membraneproteins acquire asparagine (N)-linked glycans during
biosynthesis to ensure proper folding, assembly, and traﬃcking
out of the endoplasmic reticulum (ER). The covalent
attachment of the 14-sugar oligosaccharide to a nascent chain
at an N-X-T/S consensus site, where X can be any amino acid
except proline, is catalyzed by the oligosaccharyltransferase
(OST).1,2 This ER luminal membrane protein complex is
composed of seven or eight individual subunits in eukaryotes
and undergoes a vast array of diverse functions, including
positioning the lipid-linked oligosaccharide donor and scanning
and positioning a peptide chain for N-glycosylation. N-Glycans
can be added cotranslationally to the growing peptide while it is
inserted into the ER via the translocon (Sec61 complex)3 or
post-translationally after the peptide is fully synthesized.3−7
OST catalytic subunit STT3 is the only domain of the
complex that is conserved from eukaryotes to eubacteria.8
High-resolution structures have been determined for the
bacterial and aracheal OST STT3 homologues.9,10 Despite
having sequences that are only 20% identical, these structures
are remarkably similar. For vertebrates, plants, and most insects,
there are two known eukaryotic isoforms of the OST catalytic
subunit designated STT3A and STT3B. Utilizing kinetic assays,
the OST STT3A isoform has been shown to predominantly
perform cotranslational N-glycosylation while the OST STT3B
isoform preferentially N-glycosylates peptides post-translation-
ally.5−7 Intriguingly, STT3B was found to perform cotransla-
tional N-glycosylation if STT3A is depleted, but STT3A does
not perform post-translational N-glycosylation in the absence of
STT3B,5 indicating aﬃnity diﬀerences between these diﬀerent
OST isoform complexes. While STT3A and STT3B isoforms
are ∼60% conserved, their N-glycosylation kinetics and
variations in peptide sequence recognition are not well
understood.
The primary sequence context of an N-linked glycosylation
consensus site has been known to aﬀect OST N-glycan
attachment eﬃciency, including the consensus site hydroxyl
and middle residues,11−14 speciﬁc residues upstream or
downstream of or the residue immediately following the
consensus site,15−17 and the proximity of a consensus site to
other consensus sites18 and the C-terminus.7 Although several
molecular factors aﬀect N-glycosylation eﬃciency, particularly
for NXS consensus sites that have been shown to be more
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sensitive to sequence elements than NXT sites,13,14 a plausible
mechanism for this disparity has not been determined, nor have
the biophysical ramiﬁcations of these diﬀerences been
characterized in the context of the OST STT3A and STT3B
isoforms.
Here, we use a type I transmembrane glycopeptide
(KCNE2) as a scaﬀold to determine the co- and post-
translational N-glycosylation distributions for all amino acids in
the middle residue of an NXS consensus site. We found that
middle residues with small hydrophobic, positively charged, and
polar side chains are eﬃciently cotranslationally N-glycosylated.
In contrast, consensus sites with bulky hydrophobic or
negatively charged middle X residues are often skipped during
protein translation, resulting in a higher percentage of N-
glycans being added after protein synthesis. Similar to water-
soluble and type II transmembrane proteins,5,7 the STT3A and
STT3B isoforms were primarily responsible for co- and post-
translational N-glycosylation of type I transmembrane peptides,
respectively. By comparing the amount of cotranslational N-
glycosylation to the rate of post-translational N-glycosylation,
we found that STT3A and STT3B isoforms modify NXS sites
at similar eﬃciencies, suggesting that these isoforms have a
conserved catalytic mechanism that is inﬂuenced by the side
chain of the middle residue in the consensus sequence.
■ EXPERIMENTAL PROCEDURES
Cloning and Plasmids. Human KCNE2 and KCNE4 were
cloned into the pcDNA3.1(−) vector such that ﬁve additional
methionine residues and an HA tag (YPYDVPDYA) were
added to the C-terminus of each KCNE peptide.19,20 The
second N-glycosylation consensus site was removed in KCNE2
by mutation to glutamine (N29Q). Mutations for creating
diﬀerent X residues in NXS or NXT sites were introduced
using traditional polymerase chain reaction cassette muta-
genesis (Syzygy Biotech Taq 2x MeanGreen Master Mix)
between the 5′ KpnI and 3′ BglII sites. All constructs were
conﬁrmed by DNA sequencing the entire gene.
Cell Culture and Plasmid Transfection. Chinese hamster
ovary K1 (CHO) cells were maintained in Gibco-F12K
Nutrient Mixture, Kaighn’s Modiﬁcation (with L-glutamine)
medium, supplemented with 10% FBS (Sigma) and 1%
penicillin/streptomycin. Cells were passaged using 0.5%
Trypsin-EDTA and plated onto 35 or 100 mm dishes at 80%
conﬂuency for Western blots or pulse−chase experiments,
respectively. After 24 h, the cells (35 or 100 mm dishes) were
transiently transfected with a mixture of 1.5 or 3.0 μg of KCNE
DNA and 8 or 16 μL of Lipofectamine in 1 or 2 mL of
OptiMem, respectively. After 6 h at 37 °C, the transfection
cocktail was removed and F12K medium with supplements was
added.
siRNA Transfection for Pulse−Chase and Western Blot
Experiments. Cells at 80% conﬂuency were transiently
transfected with a mixture of small interfering RNA (siRNA):
scrambled A, GAGAACUAACGCAAGAGAAdTdT; scrambled
B, GAAGGCACCGGUUAUUAGUdTdT; STT3A, GAAGA-
CACAUCAAGGAGAAdTdT; STT3B, GGACUACUCUGG-
UGGAUAAdTdT. The diﬀerent siRNA mixtures (100 nmol of
A; 150 nmol of B) were incubated (5 min) before being
combined with 16 μL of Lipofectamine 2000 in OptiMem (400
μL) for 30 min and then diluted into 2 mL of OptiMem. After
6 h at 37 °C, the transfection cocktail was removed and 2 mL of
F12K medium with supplements was added, and the cells were
incubated for 40−45 h. Another round of siRNA transfection
was performed as described above with the addition of 3 μg of
E2 DNA (NFT or NFS) to the transfection cocktail. After 6 h
at 37 °C, the transfection cocktail was removed and 2 mL of
F12K medium with supplements was added, and the cells were
incubated for an additional 40−45 h.
Pulse−Chase Assays and Cell Lysis. Pulse−chase
experiments and cell lysis were performed as previously
described.20 Brieﬂy, transfected cells were washed with PBS
and incubated for 35 min at 37 °C in Gibco DMEM High
Glucose Media (4.5 g/L D-glucose, lacking L-methionine and L-
cysteine), supplemented with 10% FBS, 1% Pen Strep, and 2
mM L-glutamine. The medium was removed, and the cells were
incubated at 37 °C for 2 min in DMEM High Glucose Media
containing 100 μCi/mL EasyTag EXPRESS [35S] Protein
Labeling Mix (PerkinElmer). The radioactive medium was
removed, and the cells washed with PBS and chased with F12K
medium for 3, 6, 9, or 12 min at 37 °C. The cells were then
washed with PBS and lysed with 750 μL of low-salt lysis buﬀer
[50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 20 mM NaF, 10
mM Na3VO4, 1% NP-40, and 1% CHAPS], which was
supplemented with protease inhibitors: 1 mM phenylmethane-
sulfonyl ﬂuoride (PMSF) and 1 μg/mL leupeptin, 1 μg/mL
pepstatin, and 1 μg/mL aprotinin (LPA). Cells were lysed for
30 min while being vigorously shaken at 4 °C, and the cell
debris was scraped and pelleted at 14000 rpm for 10 min at
room temperature.
Radioimmunoprecipitation and Electrophoresis. Ra-
dioimmunoprecipitation and electrophoresis for pulse−chase
experiments were performed as previously described.20 Brieﬂy,
Protein G agarose beads (Pierce) were prepared by being
washed in low-salt lysis buﬀer. After the cell debris had been
pelleted, the supernatant was precleared with 50 μL of beads
for 2 h at 4 °C. The beads were then spun down, and the
supernatant was transferred to new tubes containing 25 μL of
beads preincubated with 1 μL of monoclonal anti-HA antibody
(Sigma). After an overnight incubation at 4 °C, the beads were
pelleted, the supernatant was removed, and the beads were
subjected to three washes of low-salt lysis buﬀer, one wash of
high-salt buﬀer [50 mM Tris-HCl (pH 7.4), 500 mM NaCl, 1%
NP-40, 1% CHAPS, 20 mM NaF, and 10 mM Na3VO4], and a
ﬁnal wash with low-salt lysis buﬀer. For enzymatic deglycosy-
lation assays, 1 μL of Endo Hf (New England Biolabs) was
added to beads in 50 μL of low-salt lysis buﬀer and incubated at
37 °C for 1 h. Peptides were eluted from the beads with 100
mM DTT and 2× SDS gel loading buﬀer at 55 °C for 15 min.
Samples were analyzed by 15% sodium dodecyl sulfate−
polyacrylamide gel electrophoresis (SDS−PAGE), and the gels
were dehydrated for 1 h in a 30% ethanol/2% glycerol solution.
Gels were dried for 2 h at 80 °C, applied to a photostimulable
phosphor plate, and analyzed for photostimulated luminescence
with a Typhoon FLA-9000 phosphoimager after 14−42 days.
Western Blots. Cells were washed in PBS (3 × 750 μL)
and lysed with RIPA buﬀer [10 mM Tris-HCl (pH 7.4), 140
mM NaCl, 1 mM EDTA (pH 7.4), 1% Triton X-100, 0.1%
SDS, and 1% sodium deoxycholate], supplemented with
protease inhibitors (PMSF and LPA). After the sample had
vigorously shaken for 30 min at 4 °C, the cell debris was
scraped and pelleted at 14000 rpm for 10 min at room
temperature. The total protein in each sample was determined
by a bicinchonimic acid (BCA) assay and 60 μg of protein
utilized for electrophoresis. Samples were prepared by adding
100 mM DTT and 2× SDS gel loading buﬀer to the lysis
sample to yield a total volume of 50 μL. Samples were analyzed
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by 8% SDS−PAGE, transferred to a nitrocellulose membrane,
and incubated for 30 min in blocking buﬀer [5% nonfat dry
milk in Tris-buﬀered saline containing 0.2% Tween 20 (western
wash buﬀer)]. STT3 primary antibodies were obtained from R.
Gilmore,5 diluted in blocking buﬀer (1:2500 for STT3A or
1:6000 for STT3B), and allowed to incubate overnight at 4 °C.
Membranes were washed in western wash buﬀer (3 × 6 mL)
for 5 min each and incubated for 45 min at room temperature
with the rabbit anti-STT3 antibody (1:4000 for STT3A or
1:10000 for STT3B)5 in western blocking buﬀer. After being
washed (3 × 6 mL) with western wash buﬀer, the membrane
was incubated (5 min) with SuperSignal West Dura Extended
Duration Substrate (Pierce); the chemiluminescence was
captured using an LAS-3000 CCD camera and quantiﬁed by
Multi Gauge software (Fujiﬁlm).
Data Analysis. All signals were quantiﬁed using Image
Gauge software (Fujiﬁlm).20 The percentage of glycosylation
for every time point was determined by dividing the signal of
the glycosylated species by the total amount of signal (0-Gly +
1-Gly). The 12 min time point served as the percent total N-
glycosylation for every NXS and NXT construct. To determine
the cotranslational N-glycosylation contribution for each
construct, we divided the percent N-glycosylated at 0 min by
the percent N-glycosylated at 12 min. Our simpliﬁed
calculation for cotranslational N-glycosylation assumes that
the peptide substrates are fully synthesized before the 3 min
time point21 and that the observable rates for co- and post-
translational N-glycosylation are substantially diﬀerent for this
class of peptides.19 To calculate the post-translational N-
glycosylation contribution, we subtracted the cotranslational
component (0 min) from the total N-glycosylation (12 min)
and divided it by the total N-glycosylation (12 min). The
percent total N-glycosylation bar graphs show the cotransla-
tional (solid) and post-translational (slashed) contributions
with the errors between the interface representing the errors
associated with cotranslation (up error bar) and post-
translation (down error bar). Post-translational N-glycosylation
kinetic rates (k) were determined by ﬁtting the data to the
single-exponential equation y = y0 + (plateau − y0)(1 − e−kx).
PyMOL Model Generation.Middle X residue models were
generated from the PglB crystal structure [Protein Data Bank
(PDB) entry 3RCE]. Surface representations and stick models
are shown for PglB residues, and stick and sphere models are
shown for peptide residues. To ascertain the middle X residue
ﬁt into the peptide binding site, the crystallized X residue
(alanine) was mutagenized to serine (three rotamers, no steric
clash), threonine (two rotamers, no steric clash), lysine (17
rotamers, four with steric clash), glutamine (11 rotamers, three
with steric clash), arginine (19 rotamers, six with steric clash),
cysteine (three rotamers, one with steric clash), valine (three
rotamers, one with steric clash), asparagine (12 rotamers, four
with steric clash), aspartic acid (nine rotamers, three with steric
clash), methionine (nine rotamers, three with steric clash),
glutamic acid (14 rotamers, six with steric clash), isoleucine
Figure 1. Middle X residue in NXS consensus sites alters the distribution of co- and post-translational N-glycosylation of type I transmembrane
peptides. (A) Representative ﬂuorographs from pulse−chase experiments of E2 and E4 constructs containing a single NXS consensus site (E2, N6;
E4, N8). Glycosylated (1-Gly) and unglycosylated (0-Gly) species are labeled for the NSS, NFS, and NWS consensus sites. (B) The top panel is a
plot of total N-glycosylation for the NSS sites in E2 (black triangles) and E4 (gray triangles). The co- and post-translational N-glycosylation
distributions are demarcated. The bottom panel is a kinetic comparison of all six NXS sites: E2 NSS (black triangles), E4 NSS (gray triangles), E2
NFS (black squares), E4 NFS (gray squares), E2 NWS (black circles), and E4 NWS (gray circles). (C) Quantiﬁcation of the cotranslational (solid
bars), post-translational (hatched bars), and total N-glycosylation for the E2 (black) and E4 (gray) consensus sites. The error bars show the standard
error of the mean for three experiments; n.d. means not detected. The errors in the combined bar graph are denoted as follows: cotranslational
(middle bar, up), post-translational (middle bar, down), and total N-glycosylation (top bar, up).
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(two rotamers, one with steric clash), leucine (ﬁve rotamers,
four with steric clash), histidine (seven rotamers, seven with
steric clash), phenylalanine (four rotamers, four with steric
clash), tyrosine (four rotamers, four with steric clash), and
tryptophan (nine rotamers, nine with steric clash). Rotamers
shown in Figure 5 had either no steric clash or the smallest
amount of steric clash (Trp).
■ RESULTS
To determine the eﬀects of the middle X residue on the kinetics
of N-glycosylation, we needed to identify a kinetically sensitive
consensus site that would allow for the highest resolution of co-
and post-translational N-glycosylation events using rapid
metabolic pulse−chase experiments.5,19 Previously, we have
shown that members of the KCNE family (E1−E5) of type I
transmembrane peptides possess several consensus sites where
the N-glycosylation kinetics can be ﬂipped from co- to post-
translational (and vice versa) by simply switching the hydroxyl
residue in the consensus site.19,20 We chose E2 and E4 as test
substrates because they incorporate more 35S radiolabel and the
attachment of the N-glycan to these peptides depends on the
consensus site hydroxyl group.20 Because N-glycosylation
eﬃciencies of NXS consensus sites are more sensitive to the
middle X residue,13 we settled on E2 and E4 constructs that
had a single N-terminal NXS consensus site, which (i)
simpliﬁes the kinetic measurements and (ii) eliminates any
cooperativity caused by the presence of multiple consensus
sites.20
On the basis of previous consensus site X residue
eﬃciencies,13 we compared the N-glycosylation kinetics at
three sites that are eﬃciently (NSS), moderately (NFS), and
poorly (NWS) glycosylated. Figure 1A shows the unglycosy-
lated (0-Gly) and singly glycosylated (1-Gly) species for each
construct, which were conﬁrmed by endoglycosidase H
digestion (Figure 1A of the Supporting Information). The
percentage of glycosylated protein was then calculated by
normalizing the 1-Gly intensity to the total protein for each
time point and graphed as shown in Figure 1B. To determine
the co- and post-translational components, we exploited the
signiﬁcant kinetic diﬀerence between co- and post-translational
N-glycosylation5 and used a simpliﬁed convention in which co-
is deﬁned as the glycosylated protein present at the start of the
Figure 2. Large hydrophobic and negatively charged middle X residues in NXS but not NXT sites hinder cotranslational N-glycosylation. (A)
Representative ﬂuorographs from pulse−chase experiments for all middle X residues (except proline) in an E2 NXS consensus site. Glycosylated (1-
Gly) and unglycosylated (0-Gly) species are labeled. Fluorographs for NGS, NNS, NCS, and NRS are shown in Figure 1B of the Supporting
Information. (B) Bar graphs of cotranslational (solid), post-translational (hatched), and total N-glycosylation for the consensus site X residues. Polar
and small hydrophobic amino acids are colored purple, large hydrophobic amino acids green, and positively and negatively charged amino acids blue
and red, respectively. (C) Representative ﬂuorographs (left and middle) from pulse−chase experiments for middle X residues in NXT sites.
Glycosylated (1-Gly) and unglycosylated (0-Gly) species are labeled. Bar graph comparison (right) of cotranslational (solid), post-translational
(hatched), and total N-glycosylation for consensus site X residues in NXS (black) and NXT (blue) sites. All error bars show the standard error of the
mean for three experiments; n.d. means not detected. The errors in the combined bar graph are denoted as follows: cotranslational (middle bar, up),
post-translational (middle bar, down), and total N-glycosylation (top bar, up).
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chase period (0 min) and post- is deﬁned as the increase in
glycosylation measured over the experimental time course
(Figure 1B, top). Using these conventions, we compared the
amount of cotranslational, post-translational, and total N-
glycosylation for each NXS construct (Figure 1C). This initial
comparison demonstrated that the middle X residue strongly
inﬂuences the kinetics of attachment of the N-glycan to NXS
consensus sites.
Because the test NXS consensus sites in the E2 construct
displayed the widest range of cotranslational, post-translational,
and total N-glycosylation, we subsequently used this E2
construct to compare the N-glycosylation kinetics for all
middle X residues (except proline) (Figure 2 and Figure 1B of
the Supporting Information). The cotranslational, post-transla-
tional, and total N-glycosylation quantiﬁcations are shown for
each construct in Figure 2B. Cotranslational N-glycosylation
ranged from ∼20 to 85% with the most eﬃcient NXS
consensus sites containing either small (polar and hydro-
phobic) or positively charged middle X residues (Figure 2B,
left). Conversely, NXS consensus sites with either large
hydrophobic or glutamic acid middle X residues were poorly
(<50%) cotranslationally N-glycosylated. In agreement with the
temporal divisions between co- and post-translational N-
glycosylation, the largest post-translational contributors to
total N-glycosylation, for the most part, were the NXS
consensus sites that were skipped during protein translation
(Figure 2B, middle). NWS and NLS were the two exceptions,
as these were bad substrates for both co- and post-translational
N-glycosylation. This inverse relationship between co- and
post-translational N-glycosylation likely arises from the
availability of a larger pool of unglycosylated substrates available
for post-translational N-glycosylation. Nonetheless, under these
experimental conditions, post-translational N-glycosylation did
not fully compensate for NXS consensus sites containing
middle F, I, E, or M residues, keeping the total N-glycosylation
eﬃciency for these consensus sites signiﬁcantly below the
predominately cotranslational consensus sites (Figure 2B,
right).
In contrast to NXS consensus sites, previous studies have
shown that NXT sites are eﬃciently N-glycosylated regardless
of the middle X residue.7,20 Therefore, we converted the most
ineﬃcient NXS sites into NXT sites to determine which kinetic
component of N-glycosylation was responsible for the
improved N-glycan attachment. As expected, the N-glycosyla-
tion eﬃciency for all four NXT sites was signiﬁcantly improved
compared to those of their NXS counterparts (Figure 2C).
Dissection of the kinetic components of N-glycosylation
revealed that the increase in the extent of attachment of N-
glycans to these NXT sites occurred primarily during
translation. For NWT consensus sites, post-translational N-
glycosylation was also markedly improved. Thus, attachment of
N-glycans to NXT sites is unaﬀected by the middle X residue
because these sites are eﬃciently cotranslationally glycosylated.
To determine the inﬂuence of the middle X residue on post-
translational N-glycosylation kinetics, we ﬁt the pulse−chase
data for each NXS consensus site to a single-exponential
equation and compared the observed post-translational N-
glycosylation rates to cotranslational N-glycosylation eﬃciency
(Figure 3). Similar to cotranslational N-glycosylation eﬃciency
(Figure 2B), the kinetics of post-translational N-glycosylation
depended on the middle X residue, where large hydrophobic
residues had the slowest rates of post-translational N-
Figure 3. Post-translational N-glycosylation rates of NXS consensus sites mirror cotranslational N-glycosylation eﬃciency. (A) Post-translational N-
glycosylation kinetics for each NXS consensus site except tryptophan. Data are ﬁt to a single-exponential equation, and the rates are plotted in panel
B. (B) Polar and small hydrophobic amino acids are colored purple, large hydrophobic amino acids green, and positively and negatively charged
amino acids blue and red, respectively. (C) Correlation plot of co- and post-translational N-glycosylation (R2 = 0.76). The coloring is the same as in
panel B. All error bars show the standard error of the mean from three experiments; n.d. means not detected.
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glycosylation (Figure 3B and Table 1). To compare co- and
post-translational N-glycosylation for each middle residue, we
plotted the observed post-translational N-glycosylation rate
constant (kobs) versus the percentage of cotranslational N-
glycosylation (Figure 3C). Despite the large errors associated
with the inability to control substrate, enzyme, and competitor
concentrations as well as the rate of protein degradation in
living cells, these N-glycan attachment data (R2 = 0.76) suggest
that the OST STT3 isoforms associated with co- and post-
translational N-glycosylation operate at similar eﬃciencies and
by similar mechanisms.
Previous studies with water-soluble and type II trans-
membrane peptides have shown that as the protein is threaded
into the ER lumen the OST STT3A isoform performs
cotranslational N-glycosylation whereas the STT3B isoform is
responsible for post-translational N-glycosylation.5,7 Because
the N-terminus of type I transmembrane peptides without a
cleavable signal sequence is inserted into the ER en masse, we
wanted to ensure that OST STT3 enzyme speciﬁcity was not
aﬀected by the ER insertion mechanism. To identify the OST
STT3 isoform(s) associated with co- and post-translational N-
glycosylation of the NXS and NXT substrates, we speciﬁcally
reduced the protein levels of either STT3 isoform or both using
small interfering RNAs (siRNAs) and then compared the N-
glycosylation kinetics for NXS and NXT sites containing a
middle phenylalanine residue. Because the STT3 proteins are
relatively stable and do not turn over quickly, we performed
two sequential siRNA transfections (Experimental Procedures)
as previously described for STT3 isoform-speciﬁc knockdowns
in HeLa cells.5,7 This sequential knockdown reduced the levels
of STT3A protein 74 ± 3% when STT3A was targeted and 57
± 4% when STT3A and STT3B were targeted. A similar
reduction in the level of STT3B protein (63 ± 6 and 70 ± 2%)
was observed when siRNAs targeted to STT3B were used and
siRNAs targeted to STT3B and STT3A were used, respectively.
Scrambled sequences or siRNAs for the opposite isoform had
no signiﬁcant eﬀect on STT3 protein levels (Figure 2 of the
Supporting Information).
Using this siRNA transfection strategy, cells expressing the
NFS substrate were pulsed with 35S-labeled amino acids and
chased for 0−12 minutes (Figure 4A, left). For the NFS site,
reduction of either STT3A or STT3B protein did not aﬀect
cotranslational N-glycosylation (Figure 4B, left). The lack of an
eﬀect was expected because previous studies have shown that
the STT3B isoform performs cotranslational N-glycosylation
when STT3A protein levels are reduced.5 Simultaneous
knockdown of STT3A and STT3B (Figure 4A,B) conﬁrmed
that both OST isoforms must be reduced to signiﬁcantly reduce
cotranslational N-glycosylation. In contrast to cotranslational
N-glycosylation, post-translational N-glycosylation of the NFS
site was not detectable by selectively knocking down the
STT3B isoform compared to scrambled and STT3A controls
(Figure 4B, left).
We then challenged the robustness of the isoform-speciﬁc
siRNA experiments by examining the more eﬃciently N-
glycosylated NFT site (Figure 4, right panels). Similar to the
NFS site, reduction of STT3A protein levels had no eﬀect on
cotranslational N-glycosylation; reduction of STT3B protein
levels signiﬁcantly reduced post-translational N-glycosylation,
and reduction of both isoforms substantially reduced both co-
and post-translational N-glycosylation (Figure 4B, right panels).
Surprisingly, knockdown of STT3B also led to a small but
reproducible reduction in cotranslational N-glycosylation of the
NFT site (Figure 4B, top right panel). Although experimentally
signiﬁcant (Table 1 of the Supporting Information), the
STT3B-linked reduction in cotranslational N-glycosylation
likely stems from our simpliﬁed deﬁnition (the zero time
point), which for the NFT site, is likely (compared to the NFS
site) to contain faster post-translational events that occur
during the 2 min pulse (vide inf ra). If we exclude the NFT site
anomaly, our results with type I transmembrane peptides are
consistent with previous ﬁndings, where STT3A modiﬁes N-
linked consensus sites cotranslationally and STT3B modiﬁes
the skipped consensus sites post-translationally.
The recently determined eubacterial and aracheal OST
homologue structures9,10 aﬀord an opportunity to glean a
structural rationale for the eﬀect of the middle X residue on co-
and post-translational N-glycosylation. Figure 5 (top left)
shows a close-up view of the eubacterial PglB crystal structure9
Table 1. Consensus Site Middle Residue N-Glycosylationa
% co % post % total post kobs (min
−1)
E2 NXS
W 17 ± 4 nd 17 ± 4 nd
L 15 ± 2 9 ± 2 24 ± 1 −
F 31 ± 3 28 ± 3 59 ± 1 0.10 ± 0.03
I 38 ± 3 23 ± 3 61 ± 1 0.06 ± 0.02
E 40 ± 4 23 ± 5 63 ± 3 0.18 ± 0.04
M 46 ± 1 26 ± 1 72 ± 1 0.12 ± 0.02
D 64 ± 3 19 ± 4 83 ± 2 0.18 ± 0.08
K 61 ± 4 23 ± 5 84 ± 3 0.12 ± 0.02
Y 60 ± 2 26 ± 3 87 ± 3 0.21 ± 0.07
G 71 ± 2 17 ± 3 88 ± 2 0.19 ± 0.06
N 74 ± 1 14 ± 4 89 ± 4 0.25 ± 0.07
V 64 ± 1 25 ± 1 89 ± 1 0.19 ± 0.02
C 85 ± 7 5 ± 7 89 ± 3 0.22 ± 0.11
Q 75 ± 5 16 ± 5 91 ± 1 0.19 ± 0.03
R 67 ± 6 24 ± 6 91 ± 1 0.25 ± 0.02
H 81 ± 7 10 ± 8 92 ± 5 0.23 ± 0.05
S 77 ± 4 15 ± 4 92 ± 1 0.28 ± 0.05
T 72 ± 4 21 ± 4 93 ± 2 0.20 ± 0.04
A 73 ± 2 20 ± 3 93 ± 1 0.15 ± 0.05
E2 NXT
W 42 ± 2b 31 ± 3b 72 ± 2b 0.08 ± 0.03
L 68 ± 1b 18 ± 2 86 ± 2b 0.28 ± 0.05
E 71 ± 1b 17 ± 6 88 ± 6b 0.43 ± 0.14b
F 74 ± 3b 18 ± 4 93 ± 3b 0.20 ± 0.01
E4 NXS
W nd nd nd nd
F 24 ± 4 20 ± 4 44 ± 1 −
S 22 ± 2 22 ± 2 44 ± 1 −
aCotranslational, post-translational, total N-glycosylation, and post-
translational rates shown for each E2 or E4 NXS or NXT middle
residue consensus site. The percentages of co- and post-translational
N-glycosylation were determined as described in Experimental
Procedures. Values are means ± the standard error of the mean for
three pulse−chase experiments. bp < 0.05 (two-way analysis of
variance; NXT sites compared to their equivalent NXS sites). This
indicates signiﬁcance by Tukey’s multiple-comparison test (E2 NXT
values compared to equivalent E2 NXS sites). Post-translational rates
were averaged from independent pulse−chase experiments in which
the association rate (kobs) was determined by ﬁtting the data to a
single-exponential equation; nd means not detected. A dash means kobs
< 0.05, indicating post-translational rates were too slow to accurately
ﬁt.
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in which the peptide substrate containing an NAT consensus
site bends to tightly pack within the peptide recognition site of
the enzyme. Using PyMOL, we substituted middle X residues
and visually inspected each rotamer for steric and electrostatic
clashes (Experimental Procedures). The remaining panels in
Figure 5 depict the wild-type structure and middle X residue
rotamers with minimal steric clashes for the most eﬃciently
glycosylated site (cysteine), oppositely charged residues
(arginine and glutamic acid), and the worst consensus site
(tryptophan). Although deﬁnitive conclusions using a static
structure are limited and lack any kinetic information about the
binding site interactions, substituting the middle X residue into
the structure provides a qualitative picture of the molecular
gyrations needed to accommodate the diﬀerently charged and
sized amino acid side chains. In all of the panels, the middle X
residue α-carbon sits just below three PglB bottleneck residues:
N55, D465, and M318 (Figure 5). In the crystal structure, the
alanine side chain sits squarely in the pocket consisting of these
three PglB residues. When alanine is mutated to cysteine,
almost all rotamers eﬀectively maneuver around this bottleneck,
and polar residues have the potential to form hydrogen bonds
with PglB residue N55 or D465. In contrast, large hydrophobic
residues have very few rotamers in which steric clashes do not
exist and tryptophan cannot be accommodated in any rotamer
(Figure 5), highlighting the intolerance of bulky side chains in
this constrained region.
Most rotamers of the charged residues (Figure 5, Arg and
Glu) avoid the PglB bottleneck by extending their side chains
into a larger cavity between the polar (N55) and negatively
charged (D465) side chains of PglB, which may explain why
negatively charged NXS sites are less eﬃciently N-glycosylated.
On the basis of sequence alignments with the mammalian OST
STT3A and STT3B isoforms, N55 is predicted to be a glutamic
acid and serine, respectively; D465 is part of the conserved
WWD sequence that is thought to form a hydrogen bond to
the hydroxyl residue of the consensus site.9 Thus, the greater
negative charge in the STT3A pocket may underlie the subtle
diﬀerences we observed between co- and post-translational N-
glycosylation of the similarly charged (i.e., D vs E or R vs K)
residues (Figure 3C). Although PglB is a prokaryotic
homologue that modiﬁes a slightly diﬀerent consensus
sequence,22 its peptide binding site provides a structural basis
for the mammalian OST co- and post-translational N-
glycosylation kinetics of the diﬀerent NXS consensus sites.
■ DISCUSSION
Previous studies have shown that N-glycan eﬃciency is
inﬂuenced by the middle X residue in NXS, but not NXT
sites. Here, we determined the kinetic and enzymatic basis for
the eﬀect of the X residue on N-glycosylation eﬃciency. Using
rapid pulse−chase experiments with a type I transmembrane
peptide model substrate expressed in N-glycosylation proﬁcient
cells, we found a wide range of cotranslational eﬃciencies
(∼15−85%) for NXS consensus sites. In general, consensus
sites containing large hydrophobic residues (W, L, F, I, and M)
and glutamic acid were skipped (>50%) by the OST during
Figure 4. Co- and post-translational N-glycosylation of NXS and NXT sites in type I transmembrane peptides is performed by catalytic OST
isoforms STT3A and STT3B, respectively. (A) Representative ﬂuorographs from pulse-chased, siRNA-treated cells expressing either an NFS or NFT
site. The STT3 speciﬁcity of each siRNA is shown on the left: scrambled STT3A and STT3B (scr. A+B), STT3A (A), STT3B (B), and STT3A and
STT3B (A+B). Glycosylated (1-Gly) and unglycosylated (0-Gly) species are labeled. (B) Bar graphs for cotranslational (solid), post-translational
(hatched), and total N-glycosylation of NFS (black) and NFT (gray) consensus sites for the diﬀerent siRNA treatments. All error bars show the
standard error of the mean from three experiments; n.d. means not detected. *p < 0.05. The errors in the combined bar graph are denoted as follows:
cotranslational (middle bar, up), post-translational (middle bar, down), and total N-glycosylation (top bar, up).
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translation whereas small and polar residues were the most
eﬃciently modiﬁed. For NXS sites that acquire the majority of
their N-glycans during translation, post-translational N-
glycosylation eﬀectively modiﬁed the skipped sites, yielding
80−95% glycosylated protein (Table 1). However, the post-
translational N-glycosylation machinery cannot compensate for
severe cotranslational inadequacies; thus, the worst NXS sites,
in particular NWS and NLS, remain hypoglycosylated at the
end of the time course. For the corresponding NXT sites, the
addition of the methyl group to the consensus site signiﬁcantly
improved cotranslational N-glycosylation, completely amelio-
rating the eﬀect of the X residue on all consensus sites except
NWT, which requires post-translational N-glycosylation to
yield ∼70% glycosylated protein.
For the most part, our kinetic investigation of the consensus
site middle X and hydroxyl residues is in harmony with
previous in vitro glycosylation eﬃciency studies:11−14 large
hydrophobic and negatively charged middle X residues in NXS
sites are poorly glycosylated, and conversion to NXT
signiﬁcantly improves their overall N-glycosylation eﬃciency.
However, on an amino acid by amino acid basis, there are
subtle diﬀerences. The most noticeable is that negatively
charged X residues are poorly glycosylated in vitro,13 whereas in
our cell-based system, NES and NDS have eﬃciencies
comparable to those of the intermediately modiﬁed hydro-
phobic NXS consensus sites (NMS, NIS, and NFS). Given that
two diﬀerent substrates and assays were used, the congruence
of the results indicates that the eﬀect of the middle X residue
on NXS sites (and lack thereof on NXT sites) is general and
does not depend on the protein substrate.
The rapid pulse−chase experiments also allowed us to
determine whether co- and post-translational N-glycosylation
were equally aﬀected by the middle X and hydroxyl residues
(Figure 3 and Table 1). Although the measured kobs values for
the individual NXS sites were not signiﬁcantly diﬀerent from
each other (Table 1), a signiﬁcant correlation between co- and
post-translational N-glycosylation was observed (Figure 3). In
addition, switching the consensus site hydroxyl group from
serine to threonine also improved co- and post-translational N-
glycosylation similarly, yielding more cotranslational N-
glycosylation and concomitantly increasing kobs such that the
level of post-translational N-glycosylation was signiﬁcantly
increased for NET and measurable for NWT and NLT (Table
1). Together, these data suggest that co- and post-translational
N-glycosylation machineries utilize a conserved N-glycan
attachment mechanism that is similarly aﬀected by consensus
site X and hydroxyl residues. Thus, both co- and post-
translational N-glycosylation underlie the NXS and NXT N-
glycosylation eﬃciencies previously observed in in vitro
translation assays.11−14
Because the consensus site middle X and hydroxyl residues
similarly aﬀected N-glycan attachment during and after
translation, we used RNAi to identify the OST STT3 isoforms
responsible for co- and post-translational N-glycosylation of
these type I transmembrane peptide substrates. As in previous
studies with water-soluble and type II transmembrane
peptides,5,7 we found that STT3A predominantly performs
cotranslational N-glycosylation whereas STT3B predominantly
performs post-translational N-glycosylation and will perform
cotranslational modiﬁcations in the absence of STT3A (Figure
4).
Curiously, the STT3B knockdown also signiﬁcantly reduced
cotranslational N-glycosylation of the NFT substrate (Figure 4
and Table 1 of the Supporting Information). Given that it is
Figure 5. Models of middle X residues in the PglB oligosaccharyltransferase crystal structure. The top left panel shows a close-up view of the bent
NAT consensus site peptide in the PglB peptide binding site (PDB entry 3RCE):9 N, green; A, yellow; T, pink. The remaining panels show NXT
consensus site peptide models for middle X residues with various N-glycosylation eﬃciencies. The middle X residue in the crystal structure (Ala) was
mutated, and a rotamer with no steric clashes is shown for each mutant except tryptophan, which cannot be positioned without introducing a steric
clash. The three PglB residues (N55, D465, and M318) that surround the consensus site middle X residue are denoted. Numbers in the alanine
panel are given in angstroms.
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unlikely that the STT3B isoform is speciﬁcally modifying the
NFT, but not the NFS construct during protein translation, we
attribute this apparent reduction in cotranslational N-
glycosylation to post-translational (STT3B) events occurring
during the zero time point because the type I transmembrane
substrates are small (∼150 amino acids), spend approximately
10 s in the ER translocon during translation of the C-
terminus,23 and require a 2 min pulse to achieve experimentally
tractable amounts of radiolabeled protein. For comparsion,
hemagglutinin, which is twice the size of the constructs used in
our study, is readily detected ∼1 min after radiolabel treatment
of CHO cells.21 Thus, any consensus sites that are skipped
during translation can be modiﬁed post-translationally during
the pulse period. Because NFT sites are post-translationally
modiﬁed twice as fast as NFS sites, the NFT zero time point
will contain more STT3B modiﬁcations, which is what was
observed in the OST knockdown experiments (Figure 4B).
In contrast, we do not expect the chase time points (3−12
min) to be contaminated with any cotranslational events
because of the rapid (<1 min) depletion of the metabolic
radiolabel that has been observed during chase times using
proteins with evenly distributed methionines.21 Moreover, our
methionine-poor type I transmembrane substrates are inten-
tionally “back loaded” with ﬁve methionines in the C-terminus
such that any partially synthesized proteins will have minimal
radioactive signals when chased with cold media. A less precise
measurement of cotranslational but not the post-translational
events predicts that the most eﬃciently N-glycosylated
consensus sites will have an artiﬁcially higher cotranslational
N-glycosylation eﬃciency when compared to their post-
translational rates. The data in Figure 3C are consistent with
this prediction, as the highly eﬃcient polar X residues cluster
above and to the left of the linear trend. In addition, a similar
shift is observed for the other KCNE type I transmembrane
peptides where the more eﬃciently N-glycosylated consensus
sites cluster higher and to the left of the ﬁt (Figure 3 of the
Supporting Information). Overall, our knockdown studies with
type I transmembrane peptides are consistent with the previous
co- and post-translational roles assigned to the OST STT3A
and STT3B isoforms and further underscore the importance of
post-translational N-glycosylation of NXS and NXT consensus
sites skipped during protein translation.
Utilizing the known eubacterial STT3 homologue structure
PglB, we gleaned a potential structural explanation for the
spectrum of kinetic rates observed for diﬀerent X residues in
consensus sites (Figure 5). A conserved bottleneck of PglB
residues around the middle X residue in the peptide recognition
site may account for limitations in N-glycan attachment
eﬃciency for larger hydrophobic residues, where signiﬁcant
rearrangement is required to accommodate the more
voluminous side chains. To fully elucidate the molecular
nuances associated with co- and post-translational consensus
site recognition, future high-resolution structures and/or
computational docking studies with various NXS and NXT
consensus sites are needed.
This study adds to the previously identiﬁed molecular
determinants20 of co- and post-translational N-glycosylation of
the KCNE family of type I transmembrane peptides, where
mutations that shift the kinetics of N-glycosylation give rise to
cardioauditory diseases.19 Previously, we could not adequately
explain why co- and post-translational N-glycosylation of
KCNE5 consensus sites did not strongly depend on the
consensus site hydroxyl group.20 A retrospective glance at the
KCNE5 consensus sites suggests that this discrepancy is due to
the middle X residues, which are cysteine and alanine, two of
the most eﬃciently cotranslationally N-glycosylated NXS sites.
This implies that KCNE5, unlike the other KCNE peptides that
contain mostly NXT sites, evolved an eﬃcient middle X residue
versus a more eﬃcient hydroxyl residue and implicates multiple
avenues of evolution to ensure a high N-glycan occupancy rate.
In evidence, post hoc analysisa of a recent computational
study24 showed that among middle X residues in mouse
glycoprotein consensus sites determined to by occupied in vivo,
cysteine is overrepresented.
Examination of the middle X and hydroxyl residues in
previous studies utilizing water-soluble and membrane proteins
also suggests that our results with a type I transmembrane
peptide scaﬀold may be general for all full-length proteins. The
middle X residues in these post-translationally identiﬁed
consensus sites4,6,25,26 were leucine, phenylalanine, isoleucine,
and aspartic acid, the consensus sites most frequently skipped
by the cotranslational machinery (STT3A) in our study.
Moreover, all of the post-translational consensus sites in these
prior studies contained a serine hydroxyl residue, except for
consensus sites located at the extreme C-terminus of the
protein7 and factor VII.4 These exceptions underscore the need
for future studies that carefully deﬁne the molecular
determinants important for co- and post-translational N-
glycosylation of NXS and NXT consensus sites in other
topologically distinct transmembrane peptides, polytopic
membrane proteins, and water-soluble proteins.
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